The Deal
Saturday, November 21, 
11:46 am

— GE —

Top tags

You have executed a tag search on The Deal Newsweekly. To the right you will find a comprehensive list of stories tagged "GE." Below are the most-popular tags for The Deal Newsweekly. On the right of the page you will find a search box to dig deeper into our content.

Community

Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


Regulatory

Of politics and pay

How to fix executive compensation rules without breaking the companies.


Industry Insight

Before the honeymoon ends

Thinking differently about conflict resolution.


Judgment Call

The price of R&D

FAS 141(R): A new source of shareholder litigation against innovation-driven companies?



Entries tagged "GE"

Passages in India

Akil Hirani of Majumdar & Co.


Sticking with Nardelli

Bob Nardelli ran Chrysler for Cerberus. Now he's overseeing operations of other Cerberus portfolio companies.


Can private equity play the infrastructure game?

With buyouts moribund, new players have poured into some of the longest-term, low-return, politically sensitive assets out there.


Highstar: A value on experience

The veteran infrastructure investor is betting it can outshine its private equity rivals as competition for stable, long-term assets heats up.


From Gruntal to Gleacher

Fenderstock, now CEO of Broadpoint Securities, will take the helm at the new Broadpoint Gleacher. '80s merger maven Gleacher will be chairman.


Critical, if improving

Some financing markets are open, others are closed. The future remains desperately uncertain, but at least the patient shows signs of life.


Fields of green

From boom to bust to ... boom? The role of private equity in today's marketplace for renewable energies.


Queen of competition

If confirmed as assistant attorney general, Christine Varney will need to resuscitate a demoralized antitrust unit.


Darwin on the playground

Under the pressure of the credit crunch, all the cozy accommodations of media financiers begin to crumble.


Abbott leads the biotech wave

Skadden's Brian McCarthy led a team advising AMO in its sale to Abbott Labs.


Whipsawed

Dow Chemical finds it's a tough time to try to execute a multideal strategy.


GM in bankruptcy

Bailout or not, the odds are it will happen. Here's how it will unfold.


Citi directors call in Cravath

Citigroup's board has tapped Cravath's Robert Joffe for advice on the bank's many challenges.


In defense of renewable energy

Is the sector closed for business? No way.


A second set of eyes

Cravath's Robert Joffe is emerging as a go-to guy for boards of stressed companies seeking their own counsel.



footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.